Inventor · disambiguated record
Robert Owen Hughes
Also filed as: HUGHES ROBERT · HUGHES ROBERT O · HUGHES ROBERT OWEN
23 granted patents·18 pending applications·54 citations·filing 2003–2025
93Inventor score
Top patents by PatentIndex Score
41 records- 0189US11903935B2Inhibitors of SARM1 NADase activity and uses thereofWASHINGTON UNIVERSITY ST LOUIS·Filed 2021·Granted Feb 20, 2024·2 cites·3 claims
- 0287US11253503B2Inhibitors of SARM1 NADase activity and uses thereofUNIV WASHINGTON·Filed 2017·Granted Feb 22, 2022·5 cites·2 claims
- 0387US9242989B2Compounds as modulators of RORγBOEHRINGER INGELHEIM INT·Filed 2015·Granted Jan 26, 2016·4 cites·53 claims
- 0486US12083114B2Inhibitors of SARM1 in combination with neuro-protective agentsDISARM THERAPEUTICS INC·Filed 2019·Granted Sep 10, 2024·5 cites·9 claims
- 0585US7902195B2Pyridine [3,4-b] pyrazinonesPHARMACIA & UPJOHN CO LLC·Filed 2007·Granted Mar 8, 2011·13 cites·45 claims
- 0682US7244725B2Acetyl 2-hydroxy-1, 3-diaminoalkanesUPJOHN CO·Filed 2003·Granted Jul 17, 2007·16 cites·14 claims
- 0781US10266513B2Bruton's tyrosine kinase inhibitorsPFIZER·Filed 2017·Granted Apr 23, 2019·2 cites·6 claims
- 0880US10954215B2Compounds as modulators of ROR gammaBOEHRINGER INGELHEIM INT·Filed 2017·Granted Mar 23, 2021·3 cites·8 claims
- 0974US2024238264A1Inhibitors of sarm1 nadase activity and uses thereofWASHINGTON UNIVERSITY ST LOUIS·Filed 2024·Application pending·0 cites
- 1072US2024376083A1Inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1171US7645780B2Acetyl 2-hydroxy-1, 3-diaminoalkanesELAN PHARM INC·Filed 2006·Granted Jan 12, 2010·1 cites·14 claims
- 1270US8293903B23-aminocyclopentanecarboxamides as chemokine receptor agonistsHUGHES ROBERT O·Filed 2010·Granted Oct 23, 2012·2 cites·4 claims
- 1368US2021002251A1Bruton's Tyrosine Kinase InhibitorsPFIZER·Filed 2020·Application pending·0 cites
- 1466US12043613B2Inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2021·Granted Jul 23, 2024·0 cites·19 claims
- 1566US10815213B2Bruton's tyrosine kinase inhibitorsPFIZER·Filed 2019·Granted Oct 27, 2020·0 cites·4 claims
- 1665US8946413B23-aminocyclopentanecarboxamides as chemokine receptor agonistsHUGHES ROBERT O·Filed 2012·Granted Feb 3, 2015·1 cites·13 claims
- 1765US2019002465A1Compounds as modulators of ror gammaBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1862US9598415B2Compounds as modulators of RORγBOEHRINGER INGELHEIM INT·Filed 2016·Granted Mar 21, 2017·0 cites·33 claims
- 1960US12331033B2Inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2021·Granted Jun 17, 2025·0 cites·6 claims
- 2060US2018022749A1Compounds as modulators of ror gammaBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 2159US2015291554A1Bruton's Tyrosine Kinase InhibitorsPFIZER·Filed 2013·Application pending·0 cites
- 2259US2005143449A1Non-steroidal farnesoid X receptor modulators and methods for the use thereofSALK INST FOR BIOLOGICAL STUDI·Filed 2003·Application pending·0 cites
- 2358US12448374B2Inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2019·Granted Oct 21, 2025·0 cites·2 claims
- 2458US2010145056A1Acetyl 2-hydroxy-1,3-diaminoalkanesJOHN VARGHESE·Filed 2009·Application pending·0 cites
- 2558US2016075706A1Compounds as modulators of ror gammaBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 2656US2024041878A1Apelin receptor modulators for treatment of a disorder or disease associated with bbb permeabilityBIOAGE LABS INC·Filed 2023·Application pending·0 cites
- 2755US12435084B2Indazole derivatives as inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2021·Granted Oct 7, 2025·0 cites·10 claims
- 2855US2024122926A1Apelin receptor modulators for treating muscle conditionsBIOAGE LABS INC·Filed 2023·Application pending·0 cites
- 2954US12441719B2Inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2020·Granted Oct 14, 2025·0 cites·10 claims
- 3054US2024051939A1Benzopyrazole inhibitors of sarm1DISARM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3152US12338238B2Inhibitors of SARM1DISARM THERAPEUTICS INC·Filed 2019·Granted Jun 24, 2025·0 cites·16 claims
- 3249US2024252493A1Apelin Receptor Modulators for Treating Age-Related Muscle ConditionsBIOAGE LABS INC·Filed 2022·Application pending·0 cites
- 3348US2022242859A1Inhibitors of sarm1DISARM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3448US2022072019A1Inhibitors of sarm1 in combination with nad+ or a nad+ precursorDISARM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3547US2025228835A1Pyridinyloxypyridines and related compounds and their use in treating medical conditionsRECTIFY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3645US9745297B2Compounds as modulators of RORCBOEHRINGER INGELHEIM INT·Filed 2014·Granted Aug 29, 2017·0 cites·13 claims
- 3743US2021261537A1Inhibitors of sarm1DISARM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3842US9745267B2Compounds as modulators of RORCCOOK BRIAN NICHOLAS·Filed 2014·Granted Aug 29, 2017·0 cites·12 claims
- 3939US10450314B2Pteridine derivatives as modulators of ROR gammaBOEHRINGER INGELHEIM INT·Filed 2016·Granted Oct 22, 2019·0 cites·9 claims
- 4038US11358967B2Substituted pyrazino[2,3-b]pyrazines and pyrazino[2,3-c]pyridazines as modulators of ROR gammaBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jun 14, 2022·0 cites·10 claims
- 4135US2012129834A1Serotonin receptor antagonists for use in the treatment of huntington's diseaseHUGHES ROBERT·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Owen Hughes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →